Tratamento
Eli Lilly is exploring an oral version of tirzepatide, but peptide pills face significant scientific hurdles. Here's what we know about the possibility of a Mounjaro or Zepbound pill.
Curious about switching from Ozempic to an EMS generic semaglutide in Brazil? Learn what differentiates them, what ANVISA approval means, and what to discuss with your doctor.
Hypera Pharma's new Semavy pen enters Brazil's GLP-1 market at a competitive price point. Here's what to consider before making the switch.
If you're looking into Mounjaro (tirzepatide) in the United States, you've probably noticed the confusing maze of pricing, prescriptions, and online offers. Here's what you actually need to know.
Starting on Ozempic at 0.25 mg can feel like nothing is happening. Here's what science says about dose titration, individual response, and when to talk to your doctor about adjustments.
Wondering if semaglutide can prevent diabetes? Learn what research says about using GLP-1 medications as a prediabetes treatment and whether your doctor might recommend it.
If you had bariatric surgery and are now dealing with weight regain, you might wonder whether Mounjaro or Ozempic could help. Here's what the science tells us about choosing between these GLP-1 medications post-surgery.
Two powerful GLP-1 drugs are transforming weight loss treatment. Here's what the evidence shows about how they differ in practice.
Temperature-sensitive GLP-1 pens require careful handling during travel. Here's what the evidence says about storing and transporting injectable weight loss medications safely.
Nova caneta de semaglutida Yluméc é aprovada pela ANVISA para tratamento de obesidade. Entenda como funciona, para quem é indicada e o que muda no acesso a tratamentos com GLP-1 no Brasil.
If you thought all GLP-1 medications came as injections, think again. Rybelsus brings semaglutide in pill form. Here's everything you need to know about how it works and how it compares to Ozempic.
